Bookbuilding IPO | ₹300 Cr | Listed at BSE | Wed, Nov 24, 2010 - Thu, Dec 2, 2010
Claris Lifesciences IPO is a book build issue of ₹300.00 crores. The issue is entirely a fresh issue of 1.26 crore shares of ₹300.00 crore.
Claris Lifesciences IPO bidding started from Nov 24, 2010 and ended on Dec 2, 2010. The shares got listed on BSE on Dec 20, 2010.
Claris Lifesciences IPO price band is set at ₹228 per share. The lot size for an application is 22. The minimum amount of investment required by an retail is ₹5,170 (22 shares) (based on upper price). The lot size investment for sNII is 40 lots (880 shares), amounting to ₹2,00,640, and for bNII, it is 200 lots (4,400 shares), amounting to ₹10,03,200.
Edelweiss Financial Services Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Claris Lifesciences IPO RHP for detailed Information.
IPO Open
Wed, Nov 24, 2010
IPO Close
Thu, Dec 2, 2010
Issue Price
₹228 per share
Market Cap (Pre-IPO)
₹1,455.05 Cr
| IPO Date | 24 Nov to 2 Dec, 2010 |
| Listed on | Mon, Dec 20, 2010 |
| Face Value | ₹10 per share |
| Price Band | ₹228 to ₹235 |
| Issue Price | ₹228 per share |
| Lot Size | 22 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE |
| Total Issue Size | 1,26,32,477 shares (agg. up to ₹300 Cr) |
| Fresh Issue | 1,26,32,477 shares (agg. up to ₹300 Cr) |
| Share Holding Pre Issue | 5,11,85,288 shares |
| Share Holding Post Issue | 6,38,17,765 shares |
| BSE Script Code | 533288 |
| ISIN | INE562G01018 |
Claris Lifesciences IPO comprises a total issue size of 1,26,32,477 shares. Out of which, 75,79,487 (60.00%) are allocated to QIB, 12,63,247 (10.00%) allocated to NII 37,89,743 (30.00%) allocated to RII.
| Investor Category | Shares Offered | % of Total Issue | Max Allottees |
|---|---|---|---|
| QIB Shares Offered | 75,79,487 | 60.00% | NA |
| − Anchor Investor Shares Offered | 18,43,003 | 14.59% | NA |
| − QIB (Ex. Anchor) Shares Offered | 57,36,484 | 45.41% | NA |
| NII (HNI) Shares Offered | 12,63,247 | 10.00% | NA |
| Retail Shares Offered | 37,89,743 | 30.00% | 1,72,261 |
| Total Shares Offered | 1,26,32,477 | 100.00% |
Investors can bid for a minimum of 22 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 22 | ₹5,016 |
| Retail (Max) | 39 | 858 | ₹1,95,624 |
| S-HNI (Min) | 40 | 880 | ₹2,00,640 |
| S-HNI (Max) | 199 | 4,378 | ₹9,98,184 |
| B-HNI (Min) | 200 | 4,400 | ₹10,03,200 |
Incorporated in 1994, Claris Lifesciences Limited (CLL) is an Ahmedabad based pharmaceutical company. Claris is the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide. Claris offers 113 products across multiple markets and therapeutic areas. All of these products are off-patent products.
Claris's product range across various therapeutic segments, including anaesthesia, critical care, anti-infectives, renal care, infusion therapy, enteral nutrition, parenteral nutrition and oncology.
Companies more than half of the sales come from international markets and have a strong presence in regions of Latin America, the Middle East, Africa and Central, South East and Far East Asia.
Claris's manufacturing facilities are located in Ahmedabad, India and approved by foreign regulatory authorities. The manufacturing facilities are ISO 9001-2000 and WHO GMP certified.
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Setting up of a new plant comprising a small volume parenterals line, a PVC bag line, a non-PVC bag line and a fat emulsion line. | 131.59 |
| 2 | Setting up of a new manufacturing line for propofol and other fat emulsion products at the existing plant, Clarion IV. | 26.47 |
| 3 | Construction of a facility for research and development at the Clarion manufacturing facilities. | 38.41 |
| 4 | Prepayment of an identified term loan. | 45.91 |
| 5 | General corporate purposes. | 31.89 |
| KPI | |
|---|---|
| RoNW | 24.15% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 86.03% | 0.69% |
| Market Cap | ₹1,455.05 Cr. |
The Claris IPO is subscribed 1.5 times on December 2, 2010 5:00:00 PM (Day 7). The public issue subscribed 1.6 times in the retail category, 1.31 times in the QIB category, and 2.03 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 1.31 | 45,72,152 | |
| NII | 2.03 | 10,69,192 | |
| Retail | 1.6 | 32,07,577 | |
| Total | 1.5 | 88,48,921 |
Maximum Subscription Amount for Retail Investor: Rs. 2,00,000
Fitch Ratings India Private Limited has assigned an IPO Grade 3 to Claris Lifesciences Ltd IPO. This means as per Fitch, company has 'Average Fundamentals'. Fitch assigns IPO grading on a scale of 5 to 1, with Grade 5 indicating strong fundamentals and Grade 1 indicating poor fundamentals.Click here to download the Fitch IPO Grading Document for Claris Lifesciences Ltd.
Claris Lifesciences IPO, Claris IPO, Claris Lifesciences Ltd IPO Bidding, Claris Life IPO Allotment Status, Claris IPO drhp and Claris IPO listing.
Friday, November 26, 2010
Book Running Lead Manager to the issue has informed the Exchange that the CLARIS LIFESCIENCES LIMITED issue will close on 2 Dec, 2010 instead of the earlier closing day on 26 Nov, 2010.Post issue modification date has been revised to 3 Dec, 2010 instead of the earlier closing day on 27 Nov, 2010. Further price band has revised from 278/- to Rs. 293/- TO Rs. 228/- to Rs. 235/- per share.
| Price Details | BSE |
|---|---|
| Final Issue Price | ₹228.00 |
| Open | ₹224.40 |
| Low | ₹198.10 |
| High | ₹227.90 |
| Last Trade | ₹205.85 |
Claris Lifesciences IPO is a main-board IPO of 1,26,32,477 equity shares of the face value of ₹10 aggregating up to ₹300 Crores. The issue is priced at ₹228 per share. The minimum order quantity is 22.
The IPO opens on Wed, Nov 24, 2010, and closes on Thu, Dec 2, 2010.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE.
Zerodha customers can apply online in Claris Lifesciences IPO using UPI as a payment gateway. Zerodha customers can apply in Claris Lifesciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Claris Lifesciences IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Claris Lifesciences IPO opens on Wed, Nov 24, 2010 and closes on Thu, Dec 2, 2010.
Claris Lifesciences IPO lot size is 22, and the minimum amount required for application is ₹5,016.
You can apply in Claris Lifesciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Claris Lifesciences IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Claris Lifesciences IPO allotment status.
The Claris Lifesciences IPO listing date is on Mon, Dec 20, 2010.
